Work at a Startup

Flashpoint Therapeutics

flashpoint.bio

Flashpoint Therapeutics is pioneering the development of nanotechnology-enabled curative therapeutics, focusing on cancer immunotherapy. Their innovative platform allows for the co-delivery of RNA, DNA, and peptide payloads to target cells with precision, overcoming limitations of traditional therapies. With a foundation in over a decade of nanotechnology research, their candidates have shown significant improvements in potency and safety in clinical studies. The company aims to transform ineffective therapeutic components into curative solutions, positioning itself as a leader in the next generation of cancer treatments.